Mary M Zutter Selected Research

Integrin alpha2beta1

2/2011	Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice.
2/2008	alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner.
2/2007	Wound healing in the alpha2beta1 integrin-deficient mouse: altered keratinocyte biology and dysregulated matrix metalloproteinase expression.
1/2007	The alpha2beta1 integrin: a novel collectin/C1q receptor.
11/2003	Alpha2beta1 integrin and development of atherosclerosis in a mouse model: assessment of risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary M Zutter Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 04/2004
2	Thrombosis (Thrombus) 01/2014 - 11/2003
2	Neoplasm Metastasis (Metastasis) 01/2011 - 01/2007
2	Vascular System Injuries 12/2009 - 11/2003
2	Peritonitis 01/2006 - 03/2004
1	Microsatellite Instability 01/2020
1	Asthma (Bronchial Asthma) 12/2019
1	Hyperoxia 06/2014
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2014
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 06/2014
1	Retinal Neovascularization 06/2014
1	Hypoxia (Hypoxemia) 06/2014
1	Triple Negative Breast Neoplasms 03/2014
1	Insulin Resistance 02/2011
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Hypersensitivity (Allergy) 01/2011
1	Anaphylaxis (Anaphylactic Shock) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Melanoma (Melanoma, Malignant) 02/2008
1	Lewis Lung Carcinoma 02/2008
1	Pathologic Neovascularization 02/2008
1	Wounds and Injuries (Trauma) 02/2007
1	Inflammation (Inflammations) 01/2007
1	Reoviridae Infections 03/2006
1	Infections 03/2004
1	Atherosclerosis 11/2003
1	Stroke (Strokes) 11/2003
1	Myocardial Infarction 11/2003

Drug/Important Bio-Agent (IBA)

11	IntegrinsIBA 06/2014 - 11/2003
5	Integrin alpha2beta1IBA 02/2011 - 11/2003
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
3	CollagenIBA 01/2014 - 11/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2011 - 03/2004
2	ZymosanIBA 01/2006 - 03/2004
1	Biological ProductsIBA 12/2019
1	Oxygen (Dioxygen)IBA 06/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2014
1	PhosphotyrosineIBA 01/2014
1	Collagen Type I (Type I Collagen)IBA 01/2014
1	Collagen ReceptorsIBA 02/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Inflammation MediatorsIBA 01/2011
1	Fibrillar CollagensIBA 12/2009
1	Thrombin FDA Link 12/2009
1	extracellular matrix receptorIBA 01/2007
1	LigandsIBA 01/2007
1	AntibodiesIBA 03/2006
1	Junctional Adhesion Molecule AIBA 03/2006
1	Complementary DNA (cDNA)IBA 03/2006
1	Proteins (Proteins, Gene)FDA Link 03/2006
1	Integrin beta1IBA 03/2006
1	CarbohydratesIBA 03/2006
1	Integrin alpha2IBA 01/2006
1	Peptide Hydrolases (Proteases)FDA Link 04/2004
1	Carrier Proteins (Binding Protein)IBA 04/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2004
1	CytokinesIBA 03/2004

Therapy/Procedure

2	Therapeutics 01/2020 - 12/2019
1	Immunotherapy 01/2020